A Randomized, Blinded, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis

Trial Profile

A Randomized, Blinded, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 08 May 2015

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Fortress Biotech
  • Most Recent Events

    • 05 May 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 16 Dec 2013 New source identified: ClinicalTrials.gov record.
    • 10 Dec 2013 Coronade Biosciences has submitted an Investigational New Drug application to the FDA for this trial, according to a company media release. Recruitment is expected to start in the first quarter of 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top